A bioregulator peptide targeting lung and respiratory health. Supports bronchial tissue regeneration and respiratory function as part of longevity protocols.
Bronchogen is a bioregulatory peptide with targeted effects on lung tissues. It is reported to enhance respiratory epithelium, boost surfactant production, and mitigate lung inflammation. Studies in rat models suggest it can alleviate inflammation and restore lung health.
Bronchogen influences DNA transcription pathways, regulating expression of genes like NKX2-1, SCGB1A1, SCGB3A2, FOXA1, and FOXA2. It may bind deoxyribooligonucleotides containing CNG sequences (targets for cytosine DNA methylation), potentially affecting gene regulation.
Research protocols vary. A commonly cited injectable schedule is 500 mcg/day subcutaneously in the evening for 40 days; oral capsule schedules of 1-2 capsules 1-2x daily for 20-30 days followed by a multi-month break are also described.
Bronchogen is intended for laboratory research use only.
Thymagen
An immune bioregulator peptide supporting thymus function and immune system health. Essential for immune longevity.
2 mgLivagen
A liver bioregulator peptide supporting hepatic tissue regeneration and function. Essential for metabolic and detoxification health.
2 mgVesilute
A bioregulator peptide for bladder and prostate health. Supports urinary function and prostate tissue regeneration.
2 mgProstamax
A prostate bioregulator peptide supporting male reproductive health and prostate tissue function. Part of men's health optimization.
2 mg